Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

NCT05758246 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Acute Infection
Organ Failure

Interventions

DRUG: Fisetin-dose 1
DRUG: Fisetin-dose 2
DRUG: Placebo

Sponsor

University of Minnesota